Sleep Disorders in General Last Updated: May 8, 2019 CLASSIFICATION
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Case of Recurrent Sleep Paralysis: Beyond Narcolepsy
Open Access Austin Journal of Clinical Neurology A Austin Full Text Article Publishing Group Case Report A Case of Recurrent Sleep Paralysis: Beyond Narcolepsy Vijaya Yelisetty and Kanika Bagai* Abstract Department of Neurology, Vanderbilt University School of Medicine, Tennessee, USA Isolated episodes of sleep paralysis can occur in healthy people at least *Corresponding author: Kanika Bagai, Department of once in their lifetime; however recurrent isolated sleep paralysis (RISP) events Neurology, Vanderbilt Sleep Disorders Center, Vanderbilt are less common and often worrisome. Recurrent episodes of sleep paralysis University School of Medicine, A- 0118 Medical Center are often seen in patients with narcolepsy. Here, we present a unique case of North, Nashville, TN 37232, Tennessee, USA, Tel: 615- a middle-aged woman who presents with symptoms of RISP in her fifth decade 322-0283; Fax: 615-936-0223; Email: kanika.bagai@ that was not associated with narcolepsy. Vanderbilt.Edu Received: June 20, 2014; Accepted: August 20, 2014; Published: August 22, 2014 Introduction Laboratory data including complete blood count, complete metabolic panel, TSH, Vit B12, Vit D levels were within normal limits We describe a case of a 52-year-old woman who presents with as below: initial symptoms of recurrent isolated sleep paralysis. Complete blood count: WBC: 5.7k/ul; Hemoglobin 12.6 gm/dl, Case Presentation hematocrit 37%, platelets count 258k/ul. A 52 year-old woman presented to the sleep clinic with complaints Chemistries: Sodium 141 mmol/l, potassium 4.1 mmol/l, chloride of sleep difficulties and symptoms of “unable to move her body while 107 mmol/l, bicarbonate 25 mmol/l, glucose 213 mg/dl, BUN 19 mg/ in bed”. -
2020 Question Book
2020 QUESTION BOOK 13TH EDITION WHO WE ARE Welcome to the thirteenth edition of the Ninja’s Guide to PRITE! Loma Linda University Medical Center is located in sunny Southern California. about 60 miles east of Los Angeles. A part of the Adventist Health System, we provide patient care in one of the largest non-profit health systems in the nation. Loma Linda's mission is to excel in medical education, global healthcare, and community outreach, all under a central tenant: "To Make Man Whole." At the Loma Linda Department of Psychiatry, our residents are trained in many diverse patient care settings. As an official World Health Organization Collaboration Center, our department funds resident electives in Global Mental Health at locations around the world. Additionally, our residents can participate in national and international disaster relief on the LLU Behavioral Health Trauma Team. We were proud to welcome our first group of Child and Adolescent Psychiatry fellows in the Summer of 2019 and work collaboratively with 3 other residency programs within the region. Our residency didactic education is constantly evolving based upon resident feedback, and our residents have the opportunity to aid in course development. More than anything, our residency fosters an environment where residents and faculty treat each other like family. Our faculty are dedicated to resident education and professional development. We believe in "taking 'No' off the table", encouraging innovative change, and passionately supporting our residents to achieve anything they set their minds to. For over a decade our residents have volunteered their time to create The Ninja's Guide to PRITE at our Annual Ninja PRITE Workshop. -
Physiological and Pharmacological Factors of Insomnia in HIV Disease
University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Faculty Publications and Other Works -- Nursing Nursing January 1999 Physiological and pharmacological factors of insomnia in HIV disease Kenneth D. Phillips University of Tennessee - Knoxville, [email protected] Follow this and additional works at: https://trace.tennessee.edu/utk_nurspubs Part of the Critical Care Nursing Commons Recommended Citation Phillips, K. D. (1999). Physiological and pharmacological factors of insomnia in HIV disease. Journal of the Association of Nurses in AIDS Care, 10(5), 93-97. This Article is brought to you for free and open access by the Nursing at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Faculty Publications and Other Works -- Nursing by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Clinical Column JANACPhillips /Vol. Insomnia 10, No. and 5, September/OctoberHIV Disease 1999 Physiological and Pharmacological Factors of Insomnia in HIV Disease Kenneth D. Phillips, PhD, RN For almost two decades, HIV infection has been a Ungvarski, 1995), and the side effects of many antiret- progressive disease leading to early morbidity and roviral therapies and other drugs (Chohan, 1999) used mortality for more than a million Americans (Centers to treat HIV disease may produce insomnia. Although for Disease Control and Prevention [CDC], 1998). helping the client manage sleep disturbance is of great Although HIV infection strikes people of any age, it importance, available information in this area remains continues to be a disease of young persons in relatively modest. good health. Persons with HIV (PWHIV) who are in Insomnia frequently begins prior to the diagnosis of the advanced stages of the disease typically experience HIV,and it continues throughout the disease (Norman, very troubling symptoms. -
Modafinil/Armodafinil (Provigil ® /Nuvigil
Drug and Biologic Coverage Policy Effective Date ............................................ 7/1/2020 Next Review Date… ..................................... 7/1/2021 Coverage Policy Number .................................. 1501 Modafinil / Armodafinil for Individual and Family Plans Table of Contents Related Coverage Resources Coverage Policy ................................................... 1 Obstructive Sleep Apnea Treatment Services FDA Approved Indications ................................... 2 Recommended Dosing ........................................ 3 General Background ............................................ 3 Coding/ Billing Information ................................... 6 References .......................................................... 6 INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage Policies -
Daytime Sleepiness
Med Lav 2017; 108, 4: 260-266 DOI: 10.23749/mdl.v108i4.6497 Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA) Luigi Ferini-Strambi, Marco Sforza, Mattia Poletti, Federica Giarrusso, Andrea Galbiati IRCCS San Raffaele Scientific Institute, Department of Clinical Neurosciences and Università Vita-Salute San Raffaele, Milan, Italy KEY WORDS: Daytime sleepiness; Obstructive Sleep Apnea (OSA); hypersomnia PAROLE CHIAVE: Sonnolenza diurna; Apnee Ostruttive del Sonno (OSA); ipersonnia SUMMARY Excessive Daytime Sleepiness (EDS) is a common condition with a significant impact on quality of life and general health. A mild form of sleepiness can be associated with reduced reactivity and modest distractibility symptoms, but more severe symptomatic forms are characterized by an overwhelming and uncontrollable need to sleep, causing sud- den sleep attacks, amnesia and automatic behaviors. The prevalence in the general population is between 10 and 25%. Furthermore, EDS has been considered a core symptom of obstructive sleep apnea (OSA), as well as being the main symptom of primary hypersomnias such as narcolepsy types 1 and 2, and idiopathic hypersomnia. Moreover, it can be considered secondary to other sleep disorders (Restless Legs Syndrome, Chronic insomnia, Periodic Limb Movements), psychiatric conditions (Depression, Bipolar Disorder) or a consequence of the intake/abuse of drugs and/or substances. An accurate medical history cannot be sufficient for the differential diagnosis, therefore instrumental recordings by means of polysomnography and the Multiple Sleep Latency Test (MSLT) are mandatory for a correct diagnosis and treatment of the underlying cause of EDS. RIASSUNTO «Sonnolenza diurna: più di una semplice Apnea Ostruttiva nel Sonno (OSA)». L’eccessiva sonnolenza diurna (Excessive Daytime Sleepiness, EDS) è una condizione molto comune con un impatto significativo sulla qualità di vita e sulla salute in generale. -
Excessive Daytime Somnolence S44 (1)
EXCESSIVE DAYTIME SOMNOLENCE S44 (1) Excessive Daytime Somnolence Last updated: May 8, 2019 Clinical Features .................................................................................................................... 1 Differential Diagnosis ........................................................................................................... 2 Diagnosis ............................................................................................................................... 2 Treatment ............................................................................................................................... 2 NARCOLEPSY ........................................................................................................................................... 2 CLINICAL FEATURES .............................................................................................................................. 3 DIAGNOSIS ............................................................................................................................................. 4 MANAGEMENT ....................................................................................................................................... 4 IDIOPATHIC (PRIMARY) HYPERSOMNIA ................................................................................................. 5 KLEINE-LEVIN SYNDROME ...................................................................................................................... 6 SLEEP APNEA .......................................................................................................................................... -
Case Report and Review of Literature on Hypersomnia As a Result of Stroke Pradeep C
ISSN: 2638-1583 Madridge Journal of Neuroscience Case Report Open Access Sleepiness after Stroke: Case Report and Review of Literature on Hypersomnia as a Result of Stroke Pradeep C. Bollu1, Ashutosh Pandey2, Siva Prasad Pesala3 and Krishna Nalleballe1* 1Assistant Professor, Department of Neurology, University of Missouri, Columbia, USA 2Albert Einstein School of Medicine, Bronx NY, USA 3Neurologist, Department of Neurology, University of Missouri, Columbia, USA Article Info Keywords: Hypersomnia; Stroke; Daytime sleepiness; Conventional angiogram. *Corresponding author: Abbreviations: MRA: Magnetic resonance angiography; MRI: Magnetic resonance Krishna Nalleballe imaging; PLMS: Periodic limb movements in sleep; NREM: Non rapid eye movement; Assistant Professor SDB: Sleep disordered breathing Department of Neurology University of Missouri, Columbia 65212, USA Introduction Tel. 6032897308/5738821515 E-mail: [email protected] Daytime sleepiness is defined as the inability to stay awake and alert during the major waking episode of the day resulting in irrepressible need for sleep or unintended Received: March 16, 2017 lapses into drowsiness. Excessive sleepiness affects up to 5% of the general population Accepted: March 23, 2017 and can result in significant disability. Hypersomnia can be either the result of unmet Published: March 28, 2017 sleep needs or can also be due to reduced activity of alerting systems in the brain. The Citation: Bollu CP, Pandey A, Pesala SP, former can be due to sleep restriction or from sleep disruption. The International Nalleballe K. Sleepiness after Stroke: Case Classification of Sleep disorders categorize various disorders of hyper somnolence into Report and Review of Literature on Hypersomnia different sub-groups. Exaggerated sleep propensity with daytime sleepiness and/ or as a Result of Stroke. -
Sleep Disturbance in Movement Disorders
Movement disorders J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2020-325546 on 19 March 2021. Downloaded from Review Sleep disturbance in movement disorders: insights, treatments and challenges Grace A Bailey ,1 Emily K Hubbard,2 Alfonso Fasano,3,4,5 Marina AJ Tijssen ,6 Timothy Lynch,7 Kirstie N Anderson,8 Kathryn J Peall 1 ► Prepublication history ABSTRACT well established as predating motor symptom and additional material is Sleep and circadian rhythm disturbances are central onset.1 In contrast, those such as adult- onset published online only. To view please visit the journal online features of many movement disorders, exacerbating primary, idiopathic dystonia, may have poor (http:// dx. doi. org/ 10. 1136/ motor and non- motor symptoms and impairing quality sleep with evidence suggesting a link to psychi- jnnp- 2020- 325546). of life. Understanding these disturbances to sleep is atric symptom severity.2 1 clinically important and may further our understanding This review provides an overview of the Neuroscience and Mental of the underlying movement disorder. This review common sleep disorders and the evidence to Health Research Institute, Cardiff University, Cardiff, UK evaluates the current anatomical and neurochemical date for the patterns and prevalence across a 2School of Medicine, Cardiff understanding of normal sleep and the recognised spectrum of movement disorders. We discuss the University, Cardiff, UK primary sleep disorders. In addition, we undertook a 3 tools available for sleep assessment, the impact Edmond J Safra Program in systematic review of the evidence for disruption to of medication used in motor symptom manage- Parkinson’s Disease, Morton and Gloria Shulman Movement sleep across multiple movement disorders. -
Sleep Problems
Sleep Problems About 70 million Americans have some kind of sleep problem, and for many it’s a long-term problem. Even though sleep problems are very common, they are very often undiagnosed and untreated. Here are descriptions of some of the most common sleep problems. Bruxism Bruxism is grinding, gnashing, or clenching your teeth during sleep or in situations that make you feel anxious or tense. It can be mild and happen only once in a while, or it may be violent and happen often. Bruxism most often happens in the early part of the night. You may not be aware that you have bruxism until your teeth or jaws are damaged. People who have bruxism are also more likely to snore and develop sleep apnea. Hypersomnia Hypersomnia is excessive daytime sleepiness or prolonged nighttime sleep. If you have hypersomnia, you feel very drowsy during the day and have an overwhelming urge to fall asleep, even after getting enough sleep at night. You often doze, nap, or fall asleep in situations where you need or want to be awake and alert. Other symptoms may include irritability, mild depression, trouble concentrating, and memory loss. Kleine-Levin Syndrome Kleine-Levin syndrome is a rare disorder that causes you to be extremely drowsy off and on. You may sleep up to 20 hours a day. Other symptoms include eating too much, being irritable, feeling disoriented, lacking energy, and being very sensitive to noise. The disorder usually starts in the late teens and is more common in men than in women. Symptoms may last for days to weeks, then go away, and then come back. -
Sleep Disorders Preeti Devnani
SPECIAL ISSUE 1: INVITED ARTICLE Sleep Disorders Preeti Devnani ABSTRACT Sleep disorders are an increasingly important and relevant burden faced by society, impacting at the individual, community and global level. Varied presentations and lack of awareness can make accurate and timely diagnosis a challenge. Early recognition and appropriate intervention are a priority. The key characteristics, clinical presentations and management strategies of common sleep disorders such as circadian rhythm disorders, restless legs syndrome, REM behavior disorder, hypersomnia and insomnia are outlined in this review. Keywords: Hypersomnia, Insomnia, REM behavior International Journal of Head and Neck Surgery (2019): 10.5005/jp-journals-10001-1362 INTRODUCTION Department of Neurology and Sleep Disorder, Cleveland Clinic, Abu Sleep disorders are becoming increasingly common in this modern Dhabi, United Arab Emirates era, resulting from several lifestyle changes. These complaints may Corresponding Author: Preeti Devnani, Department of Neurology present excessive daytime sleepiness, lack of sleep or impaired and Sleep Disorder, Cleveland Clinic, Abu Dhabi, United Arab Emirates, quality, sleep related breathing disorders, circadian rhythm disorder e-mail: [email protected] misalignment and abnormal sleep-related movement disorders.1 How to cite this article: Devnani P. Sleep Disorders. Int J Head Neck They are associated with impaired daytime functioning, Surg 2019;10(1):4–8. increased risk of cardiovascular and cerebrovascular disease, poor Source of support: Nil glycemic control, risk of cognitive decline and impaired immunity Conflict of interest: None impacting overall morbidity and mortality. Diagnosis of sleep disorders is clinical in many scenarios, The following circadian rhythm sleep–wake disorders adapted polysomnography is a gold standard for further evaluation of from the ICSD-3: intrinsic sleep disorder such as obstructive sleep apnea (OSA) • Delayed sleep–wake phase disorder and periodic limb movement disorder (PLMD). -
The ICD-10 Classification of Mental and Behavioural Disorders : Clinical Descriptions and Diagnostic Guidelines
ICD-10 ThelCD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines | World Health Organization I Geneva I 1992 Reprinted 1993, 1994, 1995, 1998, 2000, 2002, 2004 WHO Library Cataloguing in Publication Data The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. 1.Mental disorders — classification 2.Mental disorders — diagnosis ISBN 92 4 154422 8 (NLM Classification: WM 15) © World Health Organization 1992 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications — whether for sale or for noncommercial distribution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. -
Narcolepsy and Other Disorders of Excessive Sleepiness
REVIEW ARTICLE 183 Narcolepsy and other Disorders of Excessive Sleepiness S. Chokroverty NJ Neuroscience Institute at JFK; Seton Hall University, Edison, NJ, USA ○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○○ Indian J Sleep Med 2006; 1.4, 183-188 he French physician Gelineau used the term Genetic Factors of Narcolepsy narcolepsy in 1880 to describe irresistible sleep attacks and “astasia” which has all the features Approximately 1-2% of the first-degree relatives of T narcoleptic patients compared with 0.02-0.18% in the of what was later to be named cataplexy. Reports of a large series of patients in the last century brought the general population manifest the illness, indicating a 10- entity of narcolepsy/cataplexy to the attention of the 40 times higher prevalence than existing in the general medical profession. Sleep attacks, cataplexy, sleep population. Most cases of human narcolepsy are paralysis and hypnagogic hallucinations were all grouped sporadic, but some are dominant. Twin studies of under the term narcoleptic tetrad by Yoss and Daily in narcolepsy document lack of a strong genetic influence. 1957. In 1960 Vogel discovered sleep onset rapid eye The majority of monozygotic twins were discordant for movements (SOREMs). Honda et al. discovered the narcolepsy; only 25-31% have concordance, suggesting presence of HLA-antigens in 100% of Japanese an influence of environmental factors in the etiology of narcoleptics in 1983. Finally, the discovery of narcolepsy. Narcolepsy is thought to be recessive in hypocretin or Orexin systems, reports of canine and Doberman Pinschers and Labrador Retrievers but mouse models of narcolepsy and hypocretin-1 deficiency multifactorial in poodles. Histocompatibility leucocyte in the cerebrospinal fluid of human narcolepsy/cataplexy antigens (HLA) are closely associated with narcolepsy in patients (Mignot et al.; Nishino et al.) brought narcolepsy 95-100% of cases in white and Japanese patients.